Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

A Historic Milestone in Cancer Survival: US Statistics for 2026

A Historic Milestone in Cancer Survival: US Statistics for 2026
In this article

ACS 2026 STATISTICAL REPORT

Oncology has crossed a historic threshold: for the first time, 5-year survival in cancer patients has reached 70% . This demonstrates treatment progress while also bringing new challenges.

Important Note: The figures analyzed here are US population data compiled by the American Cancer Society (ACS). Turkey's Ministry of Health published its latest comprehensive cancer statistics report in 2020, using 2017 data. We expect updated official Turkish statistics this year. Nevertheless, US data have worldwide significance as indicators of global oncology trends and treatment advances.

The 70% Cancer Survival Threshold: What Does It Mean?

The question patients ask most often is: "Doctor, what are my chances of making it?" For years, answers were limited. The American Cancer Society's CA: A Cancer Journal for Clinicians publication of the 2026 Cancer Statistics Reportfundamentally changes that answer.

A 35% decline in cancer mortality since 1991 means approximately 6 million lives saved in the US alone. However, the 70% figure can sometimes confuse patients.

How Is 70% Calculated? An Important Point for Patients

This 70% figure is an average across all cancer types and stages combined into one group.

Thyroid and prostate cancers, with 98% survival, pull the average upward; pancreatic cancer, at 13%, pulls it down. Thus, 70% is not every patient's individual chance but an indicator of modern medicine's overall progress against cancer . Each patient's course depends on cancer type, stage and molecular characteristics.

70%
5-Year Overall Survival
(49% in the 1970s)
2.1M
Expected New Cases in 2026
(Highest Number Ever)
2x
Advanced Lung Cancer
Survival Increase (5-Fold)

Seeing the Change in Data

The chart shows the dramatic rise in cancer survival since the 1970s. Three main factors contribute:

  • Early Diagnosis: Expansion of screening programs.
  • Targeted Drugs: Targeted treatments becoming standard.
  • Immunotherapy: Harnessing the body's defenses against cancer.
"We can now tell patients that their future is not predetermined. More than two-thirds of those diagnosed will overcome the disease." — American Cancer Society Leaders
Change in 5-Year Survival Rate (%)
49% 52% 58% 64% 68% 70% 1975 1985 1995 2005 2015 2026

Success by Cancer Type

Although the average has risen, this table clearly shows the gap between cancer types. Survival is nearly complete, particularly in early breast, prostate and thyroid cancers.

Thyroid 98%
Nearly Complete Success
Prostate 98%
Nearly Complete Success
Testicular 95%
High Success
Breast (Early Stage) 91%
Early Diagnosis Is Critical
Colorectal 65%
Intermediate (Rising in Younger People)
Lung 28%
Still Challenging, but Improving
Pancreatic 13%
Treatments on the Horizon

The Other Side: Inequality and Rising Cases

Despite technological progress, the 2026 report reveals how socioeconomic and racial factors affect survival. Unexplained increases in some cancers also stand out.

Cancer Type Status Clinical Implications and Causes
Endometrial (Uterine) Worsening Cases are rising 2% annually, directly linked to the obesity epidemic. Preventive measures are essential.
Colorectal Rising in Younger People An unexplained increase is occurring in people under 50. Screening age should be lowered to 45, or even 40, and symptoms taken seriously.
Prostate Inequality Mortality among African-American men is 2-4 times higher than in other groups, suggesting genetic and access inequalities.
Smoking Remains the Number 1 Enemy

Lung cancer remains the deadliest cancer, with 124,990 expected deaths. Low-dose CT screening is improving early detection, but only 18% of eligible people are screened. Raising this proportion would save lives.

DROZDOGAN ACADEMY COMMENTARY

Beyond the Numbers: Survivorship

Dear readers, 70% survival is a social responsibility as well as a biological victory. Millions of cancer survivors join our healthcare system each year. And 2.1 million new cases mean millions of new struggles for life.

Quality of Life Must Come First:
Survival alone is insufficient: cardiovascular health, sexual function and psychological well-being after treatment should be part of routine follow-up.
Managing Cancer as a Chronic Disease:
We can now manage metastatic cancers for years, as we do diabetes or hypertension. Cancer is often a manageable course rather than an inevitable end.
Prevention Is Everything:
Some countries have nearly eliminated cervical cancer through HPV vaccination. Prevention is always more effective, humane and affordable than treatment.

Source:

Siegel, R. L., Kratzer, T. B., Wagle, N. S., Sung, H., & Jemal, A. (2026). Cancer statistics, 2026. CA: A Cancer Journal for Clinicians.

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

A Historic Milestone in Cancer Survival: US Statistics for 2026

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy